The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 03, 2020
Filed:
Oct. 27, 2017
Applicant:
Abion Inc., Seoul, KR;
Inventors:
Young Deug Kim, Incheon, KR;
Eun Ji Park, Daegu, KR;
Yejin Kim, Daegu, KR;
Young Kee Shin, Seoul, KR;
Jun Young Choi, Gyeonggi-do, KR;
Assignee:
ABION INC., Seoul, KR;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 47/50 (2017.01); A61K 47/68 (2017.01); C07K 16/28 (2006.01); A61P 35/00 (2006.01); C07K 16/30 (2006.01); C08G 83/00 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 47/50 (2017.08); A61K 47/6809 (2017.08); A61K 47/6851 (2017.08); A61K 47/6885 (2017.08); A61P 35/00 (2018.01); C07K 16/28 (2013.01); C07K 16/3053 (2013.01); C08G 83/003 (2013.01); A61K 2039/505 (2013.01); C07K 2317/24 (2013.01); C07K 2317/56 (2013.01); C07K 2317/73 (2013.01); C07K 2317/77 (2013.01); C07K 2317/92 (2013.01);
Abstract
An immune conjugate according to the present invention provides a pharmaceutical composition, which can be used in the target-oriented drug treatment by conjugating a dendron allowing a plurality of drugs to be bound to a surface thereof and a target-directed antibody, and especially, can deliver high concentrations of drugs in a tumor-specific manner to exhibit a strong anticancer effect by conjugating a hydrophilic dendron, to which a plurality of anticancer drugs are bound, to an antibody.